Heron Therapeutics HRTX Cash Flow Statement (2010-2026)

NASDAQ HRTX
$0.35 -0.01 (-1.77%)
At close: Oct 20, 2026 · 4:00 PM EDT
Reported Financials

Heron Therapeutics Quarterly Cash Flow Statement

Periods 65 quarters
Latest Jun 2026

Heron Therapeutics reported cash from operations of -$2.21M and free cash flow of -$2.35M for the quarter ended Jun 2026, up 79.6% year over year. This cash flow statement covers 65 quarters of results from Jun 2010 through Jun 2026, standardized by Business Quant from the company’s SEC filings.

Cash Flow StatementCash Flow Jun2010 Sep2010 Dec2010 Mar2011 Jun2011 Sep2011 Dec2011 Mar2012 Jun2012 Sep2012 Dec2012 Mar2013 Jun2013 Sep2013 Dec2013 Mar2014 Jun2014 Sep2014 Dec2014 Mar2015 Jun2015 Sep2015 Dec2015 Mar2016 Jun2016 Sep2016 Dec2016 Mar2017 Jun2017 Sep2017 Dec2017 Mar2018 Jun2018 Sep2018 Dec2018 Mar2019 Jun2019 Sep2019 Dec2019 Mar2020 Jun2020 Sep2020 Dec2020 Mar2021 Jun2021 Sep2021 Dec2021 Mar2022 Jun2022 Sep2022 Dec2022 Mar2023 Jun2023 Sep2023 Dec2023 Mar2024 Jun2024 Sep2024 Dec2024 Mar2025 Jun2025 Sep2025 Dec2025 Mar2026 Jun2026
Operating Activities
Net Income
-52.41M-54.65M-63.89M-56.36M-41.91M-19.87M-32.77M-42.06M-25.01M-10.72M-3.16M-9.24M-4.85M3.66M2.64M-2.38M-17.50M-2.95M-8.11M-5.49M
Depreciation, Depletion & Amortization
Amortization of Deferred ChargesAmort. Deferred Charges
0.05M0.05M0.05M0.05M0.05M0.05M0.05M0.05M0.09M0.09M0.32M0.25M0.21M0.21M0.09M0.24M0.22M0.23M
Depreciation & Amortization (CF)Dep. & Amort.
0.75M0.79M0.72M0.67M0.71M0.79M0.72M0.74M0.73M0.72M0.69M0.64M0.58M0.59M0.55M0.61M0.62M0.54M0.53M0.45M
Share-based CompensationStock Comp.
11.24M12.89M10.92M10.35M11.20M10.51M7.95M13.90M6.68M4.32M3.38M4.57M2.72M2.30M2.51M2.80M2.85M2.18M2.98M3.18M
Cash from Discontinued OperationsCash from Discont. Ops
Gains from Sales and DivestituresGains Divest
-0.10M0.02M0.01M0.03M-0.13M
Gains from Investment SecuritiesGains Investment
Asset Writedowns and ImpairmentWritedown
0.16M0.12M0.05M0.04M0.04M0.08M0.15M0.16M0.15M0.15M0.17M3.27M0.83M0.14M0.41M0.01M0.01M
Other non-cash itemsOther Non-Cash
11.34M
Change in Working Capital
Change in ReceivablesChange Receivables
0.47M-7.59M5.60M-0.80M1.89M9.86M-0.60M25.25M-12.90M-3.66M5.19M8.39M-6.67M11.84M-0.15M1.20M1.12M8.54M-5.89M5.88M
Change in InventoryChange Inventory
-1.30M6.88M8.09M4.85M-9.08M2.33M-2.51M-7.44M-2.62M0.10M0.36M0.39M3.09M7.21M3.77M16.03M-2.94M14.19M0.17M0.68M
Change in Account PayablesChange Payables
-5.36M-2.08M4.42M5.58M-7.26M-3.32M0.84M-2.11M-0.10M1.38M-2.40M9.39M-0.04M1.52M0.62M-0.30M-0.02M-3.02M-0.02M2.57M
Change in Accured ExpensesChange Accured Exp.
2.33M-7.67M-3.05M4.11M-1.62M13.45M-3.91M0.35M0.52M-1.15M2.01M-4.14M0.93M1.54M5.71M-1.17M2.51M3.55M-2.88M0.24M
Change in Other Operating AssetsOther Assets Change
3.91M2.69M0.41M-4.50M-1.63M4.72M-0.91M-9.46M-0.17M-4.89M0.22M-0.29M3.84M6.16M8.60M-9.30M5.25M-5.43M-1.12M-1.20M
Change in Other Operating LiabilitiesOther Liabilities Change
-6.76M6.57M13.56M6.39M-6.37M-12.83M-3.20M-1.39M4.86M-2.45M-2.35M-2.26M4.81M3.01M-5.47M-2.62M2.30M7.19M-0.61M-0.41M
Other Working Capital ChangesOther WC Changes
-10.67M3.87M13.16M10.90M-4.74M-17.55M-2.29M8.07M5.03M2.44M-2.57M-1.97M0.98M-3.15M-14.07M6.69M-2.95M12.61M0.51M0.79M
Cash from OperationsCash from Ops.
-53.17M-45.26M-43.94M-28.37M-37.07M-37.53M-24.90M-27.17M-9.18M2.46M-9.52M-4.60M3.37M-11.78M-8.87M-10.87M1.33M-9.18M-1.54M-2.21M
Investing Activities
Capital ExpendituresCapex
1.53M0.39M1.04M0.32M0.05M0.41M0.22M0.28M0.79M0.25M0.43M0.64M0.11M0.21M0.39M0.14M
Sales of Property, Plant and EquipmentPP&E (Sale)
0.06M0.17M0.00M0.04M0.01M0.03M0.02M
Change in Property, Plant and EquipmentChange in PP&E
-1.53M-0.39M-0.99M-0.32M0.12M-0.41M-0.22M-0.28M-0.79M-0.25M-0.43M-0.64M-0.07M-0.20M0.03M0.02M-0.39M-0.14M
Purchase of InvestmentsInvestments Purchased
29.28M37.90M38.02M20.92M68.17M18.57M13.94M14.44M35.93M23.35M37.89M27.21M25.65M12.34M22.90M9.19M6.13M12.57M13.14M14.72M
Sale and Maturity of InvestmentsInvestments Sold
52.44M14.00M49.96M41.00M32.00M21.00M51.00M27.94M13.50M14.75M39.17M29.89M30.05M24.37M25.24M16.72M17.96M7.10M12.59M11.59M
Change in Acquisitions & DivestmentsChange Acquisitions
Cash from Investing ActivitiesCash from Investing
21.63M-24.26M10.95M19.76M-36.05M2.02M36.83M13.22M-23.22M-8.84M1.28M2.05M3.97M11.42M2.27M7.33M11.86M-5.46M-0.94M-3.27M
Financing Activities
Debt Issuance and Repayment
Long-Term Debt IssuancesLT Debt Issuance
-0.02M-4.79M
Non-Current Debt
-0.02M-4.79M
Net Debt Issuances and RepaymentsNet Debt Issuance
-0.02M-4.79M
Change in Capital Stock
Common Stock IssuedStock Issued
0.61M75.16M0.65M29.76M0.20M0.46M19.84M-1.27M
Net Shares Issued and RepurchasedNet Shares Issued
0.61M75.16M0.65M29.76M0.20M0.46M19.84M-1.27M
Net Equity Issued and RepurchasedNet Equity Issued
0.61M75.16M0.65M29.76M0.20M0.46M19.84M-1.27M
Other financing activitiesOther financing
-23.47M
Cash from Financing ActivitiesCash from Financing
-0.07M0.49M-0.64M0.32M74.94M0.44M-0.21M0.32M53.80M0.20M0.01M0.49M0.01M0.42M0.06M0.78M13.36M0.22M-0.05M0.08M
Additional items
Change in Cash
-31.60M-69.03M-33.63M-8.30M1.83M-35.07M11.73M-13.63M21.40M-6.18M-8.23M-2.06M7.36M0.06M-6.53M-2.75M26.55M-14.42M-2.53M-5.40M
Ending Cash Balance
159.57M90.54M56.91M48.61M50.44M15.36M27.09M13.46M34.86M28.68M20.45M18.39M25.74M25.80M19.27M16.52M43.07M28.65M26.12M20.72M
Free Cash FlowFCF
-54.70M-45.65M-44.98M-28.70M-37.11M-37.95M-25.12M-27.44M-9.97M2.21M-9.52M-4.60M2.94M-12.42M-8.98M-11.08M1.33M-9.18M-1.93M-2.35M
Net Cash FlowNCF
-31.60M-69.03M-33.63M-8.30M1.83M-35.07M11.73M-13.63M21.40M-6.18M-8.23M-2.06M7.36M0.06M-6.53M-2.75M26.55M-14.42M-2.53M-5.40M
Interest Paid
1.13M0.16M1.77M0.65M1.78M0.66M1.77M0.64M1.78M1.45M2.65M2.63M2.69M

Heron Therapeutics Cash Flow Statement API

Pull Heron Therapeutics's standardized financial statements into your own models, spreadsheets and apps with the Business Quant Financial Statements API. The request below follows the statement, frequency and period selected above. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/statements?ticker=HRTX&statement=CF&frequency=Quarter&period=all&api_key=YOUR_API_KEY